Bowel Preparation for Colonoscopy
Conditions
Keywords
Magnesium sulfate, colonoscopy, bowel preparation, adenoma detection rate
Brief summary
Magnesium salts such as magnesium citrate are often combined with polyethylene glycol to make the intestinal preparation before colonoscopy, which has shown high cleaning efficacy. Magnesium sulfate combined with polyethylene glycol is less used in the world. This multicenter, randomized, controlled trial is aimed at to evaluate the efficacy and safety of magnesium sulfate combined with low-volume polyethylene glycol for preoperative bowel preparation for colonoscopy.
Interventions
Subjects in Group A will use a regimen combining magnesium sulfate and polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. 1 litter of polyethylene glycol is taken at 8pm the day before the colonoscopy and 50 gram of magnesium sulfate is taken 4-6 hours before the colonoscopy, and then drink 2000 ml of water within 2 hours.
Subjects in Group B will use a regimen with 3L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 3 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.
Subjects in Group C will use a regimen with 4L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 4 liters of polyethylene glycol solution is taken in split dosing, with 2 liters taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.
Sponsors
Study design
Eligibility
Inclusion criteria
* 18-75 years old, male or female * To undergo screening, surveillance and diagnostic colonoscopy * Signed written informed consent
Exclusion criteria
* Subjects with therapeutic colonoscopy for colorectal polyps * Subjects with confirmed or suspected gastrointestinal obstruction, gastric retention, gastroparesis, gastric emptying disorder, or acute gastrointestinal bleeding * Subjects with confirmed or suspected colorectal cancer, inflammatory bowel disease, toxic colitis, or toxic megacolon * Subjects with renal or liver dysfunction, congestive heart failure or rhabdomyolysis * Subjects with ascites, suspected electrolyte abnormalities, or uncorrected dehydration * Subjects with constipation (\<3 times a week, difficult defecation, dry stool, less amount) * Subjects with serious cardiac and cerebrovascular diseases,suffering from metabolic disease or endocrine disease * Subjects who had previously undergone colorectal resection * Women with positive pregnancy tests or pregnancy plans, and women in lactation or allergic to the investigational drugs and their ingredients * Subjects who are participating in other clinical trials or receiving special drugs * Subjects with any other conditions that the investigator considered inappropriate for inclusion
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adequate bowel preparation rate | 30minutes | Defined as the proportion of participants with score ≥ 2 for all colon segment (right-side colon, transverse colon, and left-side colon) according to the Boston Bowel Preparation Scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Excellent bowel preparation rate | 30minutes | The proportion of participants with total score ≥ 8 according to Boston Bowel Preparation Scale. |
| BBPS score (including total score, left colon, transverse colon, and right colon) | 30minutes | — |
| Adenoma detection rate | 10 days | — |
| Bowel preparation completion rate | 30minutes | — |
| Electrolyte levels | 8 hours | — |